161 related articles for article (PubMed ID: 15197072)
1. Recurrent anterior uveitis in patients with Vogt-Koyanagi-Harada syndrome.
Taylor S; Lightman S
Arch Ophthalmol; 2004 Jun; 122(6):922-3. PubMed ID: 15197072
[No Abstract] [Full Text] [Related]
2. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada disease in 3-year-old boy.
Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
[No Abstract] [Full Text] [Related]
4. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Agarwal M; Ganesh SK; Biswas J
Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
[TBL] [Abstract][Full Text] [Related]
5. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
7. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
9. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J
Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features, risk factors and progresses on treatment of recurrent Vogt-Koyanagi-Harada disease].
Jia SS; Zhao C; Liu XS; Zhang MF
Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):317-320. PubMed ID: 28412807
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
13. Effect of immunosuppressive therapy on ocular blood flow in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Alsarhani W; Alzubaidi A; Gikandi PW
Acta Ophthalmol; 2021 Dec; 99(8):e1405-e1414. PubMed ID: 33719161
[TBL] [Abstract][Full Text] [Related]
14. Formation of pseudodiscs in chronic recurrent Vogt-Koyanagi-Harada syndrome.
Liao HR; Juang CJ
Can J Ophthalmol; 1989 Oct; 24(6):280-2. PubMed ID: 2611713
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents.
Rao NA
Ocul Immunol Inflamm; 2006 Apr; 14(2):71-2. PubMed ID: 16597535
[No Abstract] [Full Text] [Related]
16. The Choroidal Vascularity Index Decreases and Choroidal Thickness Increases in Vogt-Koyanagi-Harada Disease Patients During a Recurrent Anterior Uveitis Attack.
Liu S; Du L; Zhou Q; Zhang Q; Hu K; Qi J; Liang L; Zhou C; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2018; 26(8):1237-1243. PubMed ID: 28914578
[TBL] [Abstract][Full Text] [Related]
17. [Systemic management of autoimmune anterior uveitis].
Bachta A; Tłustochowicz M
Klin Oczna; 2005; 107(10-12):710-4. PubMed ID: 16619827
[TBL] [Abstract][Full Text] [Related]
18. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
[TBL] [Abstract][Full Text] [Related]
19. Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
Yang HK; Park KH; Kim JS; Hwang JM
Can J Ophthalmol; 2014 Apr; 49(2):e54-6. PubMed ID: 24767242
[No Abstract] [Full Text] [Related]
20. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
Bacsal K; Wen DS; Chee SP
Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
